Gapping down
In reaction to earnings/guidance:
- BCOV -16.9%, TWLO -14% (also COO to resign, names new COO), NTGR -10.8% (also authorizes repurchase of up to an incremental 10% of shares), RBBN -8.5%, GSHD -8.4%, FLS -5.9%, FLEX -5.6%, UPWK -5.5%, EBAY -5.5%, RE -5.2%, SWK -5%, DBD -5%, AXTI -4.9%, TDOC -4.9%, MD -4.9%, TW -4.7%, RDS.A -4.4%, CLB -4.3%, PLXS -4.1%, SHOP -4.1%, EHC -4%, CMCO -3.9%, NGVT -3.7%, PEGA -3.6%, NOW -3.5%, NVCR -3.4%, AGI -3.3%, EW -3.1%, TFX -3.1%, CDE -2.9% (also also selling its La Preciosa project to ASM), RS -2.8%, CASH -2.7%, MYRG -2.3%, FARO -2.1%, TREE -2.1%, EQT -2%, CARR -2%, NLSN -2%, FORM -1.9%, PPC -1.9%, NEM -1.9%, MCO -1.9%, TROX -1.8%, EXP -1.8%, AR -1.6%, PRLB -1.6%, BAX -1.6%, MO -1.4%, LIN -1.2%, EVTC -0.9% (also selected as the issuer processor of a new payment product for Caja Popular), CTSH -0.9%, INSM -0.9%
Other news:
- RFL -73% (AVENGER 500 Phase 3 clinical trial for CPI-613 did not meet its primary endpoint)
- VWE -5.6% (stock offering)
- RPTX -4.6% (prices offering of 4 mln shares of common stock at $22.00 per share)
- KREF -4.6% (prices offering of 5 mln shares of common stock for gross proceeds of $110.0 mln)
- SESN -3.5% (provides FDA warning letter clarity)
- OSMT -2.7% (stock offering)
Analyst comments:
- BJ -2.9% (downgraded to Neutral from Buy at BofA Securities)
- CAR -2.8% (downgraded to Neutral from Buy at BofA Securities)
- CVI -1.9% (downgraded to Underperform from Neutral at Credit Suisse)
- SHW -1.4% (downgraded to Neutral from Buy at BofA Securities)
- TMX -1% (downgraded to Neutral from Outperform at Robert W. Baird)